The Allstate Corporation

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 1,657 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• Allstate files its own Form 13F-HR (CIK 0000899051). The Q2 2026 filing (filed 13 Aug 2026, period 30 Jun 2026, accession 0001140361-26-032699) reports 1,524 information-table lines totaling approximately $10.01 billion in reported value. This is Allstate's own general-account investment portfolio managed with in-house discretion (a broadly diversified book of public equities across hundreds of issuers), not client assets and not a concentrated set of strategic stakes. Per the brief's insurer-trap rule, this is treated as investment portfolio, not strategic ownership, and no positions from it are recorded as holdings.
• Searched Allstate's Q2 2026 10-Q (accession 0000899051-26-000118) and FY2025 10-K (accession 0000899051-26-000031) for: 'equity method', 'limited partnership interests', 'unconsolidated', 'joint venture', 'strategic investment', 'other investments', 'National General', 'Allstate Health and Benefits', 'divestiture', 'held for sale', 'noncontrolling interest', 'Arity'. Findings: (1) The FY2025 10-K reports $8,844 million of Limited partnership interests at 31 Dec 2025 ($7.25bn private equity funds, $1.45bn real estate funds, $146m other funds), a fund-of-funds style aggregate with no individual investee named anywhere in either filing; per the brief's rule against assigning a combined balance to one investee, no holdings rows are derived from it. (2) The 10-Q separately shows $99-101 million of securities measured under the equity method / measurement alternative, again as an unnamed aggregate. (3) National General is referenced only in litigation and reinsurance-program disclosures as a consolidated Allstate operating subsidiary (wholly owned, excluded per the brief), not a minority stake. (4) The Allstate Health and Benefits segment's two constituent businesses were both fully divested with closed cash sales in 2025: the employer voluntary benefits business (American Heritage Life Insurance Co and American Heritage Service Co) closed 1 Apr 2025 for a recognized gain of $888 million pre-tax, and the group health business (Direct General Life Insurance Co, NSM Sales Corp, The Association Benefits Solution LLC) closed 1 Jul 2025 for a recognized gain of $715 million pre-tax; neither filing discloses any retained equity stake, transition ownership interest, or earn-out equity in the divested entities, so these are excluded as closed sales with no residual stake, not treated as current holdings. (5) Arity (telematics) is listed among Allstate's own wholly owned, consolidated Protection Services businesses, not a stake in another company; the modest noncontrolling-interest balance on Allstate's own balance sheet (-$21 million at 31 Dec 2025) reflects minority partners' stakes IN Allstate-controlled subsidiaries, the reverse direction from what this file records. On this basis, holdings is empty: no material named strategic or minority stake in another operating company, JV, or unconsolidated affiliate was found.
• Vanguard case: Vanguard Group Inc (CIK 0000102909) filed 13F-NT (no holdings) for Q2 2026. Per the brief this is the successors-summed case: Vanguard Capital Management LLC and Vanguard Portfolio Management LLC are summed into one 'The Vanguard Group' register row (30,425,744 shares) rather than listing Vanguard more than once. This is NOT the single-13F-HR-row case.
• Capital Group check: Capital World Investors (CIK 0001422849), Capital International Investors (CIK 0001562230) and Capital Research Global Investors (CIK 0001422848) were each checked against their own Q2 2026 13F-HR information tables (searched both 'ALLSTATE' and the shorter fragment 'ALLST'); none of the three holds any Allstate common stock (CUSIP 020002101 absent from all three tables), so no 'Capital Group' row is included in the register.
• Register reconciliation, 13F vs proxy 13G/13D data. Allstate's 2026 DEF 14A 'Security Ownership of Certain Beneficial Owners' table (as of 1 Apr 2026) lists only one holder above 5 percent: BlackRock Inc., 22,236,119 shares (8.4%), sourced from a Schedule 13G/A whose most recent share detail cited in the proxy footnote is as of 31 Dec 2024, over a year stale relative to this register's Q2 2026 13F-HR figure of 22,860,586 shares (a real increase, not a data error, given both are genuine filings of different types and dates). The same DEF 14A footnote states that on 26 Mar 2026 The Vanguard Group, Inc. filed a Schedule 13G/A reporting an internal realignment (effective 12 Jan 2026) under which Vanguard's subsidiaries now report beneficial ownership on a disaggregated basis, so Vanguard's own consolidated 13G/A figure for Allstate collapsed to 0 shares and it therefore no longer appears as a named 5-percent owner in the proxy's own table, even though the two Vanguard successor entities plainly still hold a combined 30.4 million ALL shares per their own Q2 2026 13F-HRs (used in this register). Both figures are recorded here rather than one overwriting the other.
• No Schedule 13D or fresh 13G/13G-A filed directly against Allstate's own CIK (0000899051) since 13 Feb 2024 was found in the EDGAR filing index for that CIK, despite the 2026 proxy's own citation of a 26 Mar 2026 Vanguard 13G/A; this appears to be an EDGAR full-text-search indexing lag for the post-reorganisation Vanguard filer rather than an absence of the filing itself. The register therefore relies on Q2 2026 13F-HR data plus the proxy's own beneficial-ownership tables rather than an independently retrieved fresh 13D/G.
• Market capitalisation ($65.62 billion) and share price ($259.51) are stockanalysis.com's figures as of 17 August 2026 (intraday). Cross-check: 252,857,950 shares x $259.51 implies approximately $65.62 billion, consistent with the reported market cap.
• Percentages are computed against 252,857,950 common shares outstanding as of 16 July 2026 (Q2 2026 10-Q cover page), including for the two proxy-sourced insider rows, whose underlying share counts are as of the proxy's own record date of 1 March 2026; the proxy itself does not disclose an alternative shares-outstanding figure to use as a denominator alongside that table.
• Self-gate check: summing the eleven non-aggregate, non-insider, non-member register rows (Vanguard through Norges Bank) gives 110,139,797 shares against 252,857,950 shares outstanding, or 43.56%, within the expected 25 to 45 percent range for this register.